UNSPSC 51284027: Doxycycline hyclate

This classification denotes a tetracycline antibiotic with the molecular formula 2C22H24N2O8.C2H6O.2ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 19XTS3T51U, chemically known as 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy- 6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrate but more generally known as doxycycline hyclate, which bears US NIH Compound Identifier 5281011.

UNSPSC 51284027 Doxycycline hyclate is a Commodity-tier code representing individual pharmaceutical products procured by state and local health agencies, but recent state and local solicitations show minimal relevant activity specifically targeting this drug; the opportunities tagged under this code instead reflect broader pharmaceutical procurement categories including naloxone, generic multi-source pharmaceuticals, OTC products, and emergency medical supplies that state and local health departments, fire departments, and purchasing coalitions acquire through competitive bid and cooperative purchasing vehicles. State and local issuing bodies soliciting under this code tier include county health departments (Seminole County, Florida), state health agencies (Texas HHS Commission), municipal fire departments (City of Tampa), and multistate cooperative purchasing organizations (Minnesota MMCAP); these jurisdictions typically source pharmaceutical products through direct manufacturer contracts, authorized wholesale distribution networks, or sheltered-market procurements designated for small local business enterprises.

Recent opportunities reflect procurement activity across Florida, Texas, Minnesota, and Oregon, spanning health initiative support, prescription fulfillment program development, and emergency response supply chains. Seminole County, Florida issued IFB 60459723LAS (due July 26, 2023) seeking 1,900 units of naloxone and 800 drug deactivation systems annually through quarterly deliveries with fixed-fee pricing. The City of Tampa issued IFB 26P00145 (due March 13, 2026) for medical and first aid supplies to the Tampa Fire Department Rescue Division under a $700,000 estimated contract with a 5 percent bid discount for certified Small Local Business Enterprises. Texas HHS Commission issued RFI HHS0017013 (due April 3, 2026) to gather vendor capabilities on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels. Minnesota MMCAP issued RFP S1070000015802 (due March 26, 2026) establishing multiple contracts for generic multi-source pharmaceuticals and OTC products through authorized wholesalers, with awards effective July 1, 2026 and contract terms through June 30, 2028.